Last update 08 May 2025

CM-2395

Overview

Basic Info

Drug Type
Unknown
Synonyms
Target
5-HT1B receptor x D2 receptor x α2C-AR
Action
agonists, antagonists
Mechanism
5-HT1B receptor agonists(Serotonin 1b (5-HT1b) receptor agonists), D2 receptor agonists(Dopamine D2 receptor agonists), α2C-AR antagonists(Alpha-2c adrenergic receptor antagonists)
Therapeutic Areas
Other Diseases
Active Indication-
Inactive Indication
Schizophrenia
Originator Organization
Cenomed BioSciences LLC
Active Organization-
Inactive Organization
Cenomed BioSciences LLC
License Organization-
Drug Highest PhasePendingClinical
First Approval Date-
Regulation-

Related

100 Clinical Results associated with CM-2395
Login to view more data
100 Translational Medicine associated with CM-2395
Login to view more data
100 Patents (Medical) associated with CM-2395
Login to view more data
100 Deals associated with CM-2395
Login to view more data

R&D Status

Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free